Buyer must give Seller written notice of the existence of each claim involving Product (whether based in contract, breach of warranty, negligence, strict liability, other tort or otherwise) within the earlier of thirty (30) days after receipt of the quantity of Product forming the basis for the claim or applicable shelf-life expiration, if any. No modification or addition to the contract shall occur by the acknowledgment or acceptance by Seller of a purchase order, acknowledgment, release or other form submitted by Buyer containing additional or different terms or conditions. 20.

Buyer must give Seller written notice of the existence of each claim involving Product (whether based in contract, breach of warranty, negligence, strict liability, other tort or otherwise) within the earlier of thirty (30) days after receipt of the quantity of Product forming the basis for the claim or applicable shelf-life expiration, if any. No modification or addition to the contract shall occur by the acknowledgment or acceptance by Seller of a purchase order, acknowledgment, release or other form submitted by Buyer containing additional or different terms or conditions. 20.

Buyer must give Seller written notice of the existence of each claim involving Product (whether based in contract, breach of warranty, negligence, strict liability, other tort or otherwise) within the earlier of thirty (30) days after receipt of the quantity of Product forming the basis for the claim or applicable shelf-life expiration, if any. No modification or addition to the contract shall occur by the acknowledgment or acceptance by Seller of a purchase order, acknowledgment, release or other form submitted by Buyer containing additional or different terms or conditions. 21.

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: • Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; • The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; • Disruptions or inefficiencies in our supply chain, logistics, or operations; • Changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change; • Fluctuations in raw material prices, quality and supply, and in energy prices and supply; • Demand for our products and services; • Production outages or material costs associated with scheduled or unscheduled maintenance programs; • Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; • Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; • Information systems failures and cyberattacks; • Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; • Our ability to achieve strategic objectives and successfully integrate acquisitions, including the implementation of a cloud-based enterprise resource planning system, S/4HANA; • Other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts and any recessionary conditions; and • Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2023 under Item 1A, “Risk Factors.” You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.

Reconciliation to Adjusted EPS Excluding Special Items and Impacts of February 2020 Equity Offering and May 2020 Debt Offering Three Months Ended June 30, 2020 Net income from continuing operations attributable to Avient common shareholders $ 23.0 Special items, after tax(1) 2.6 After tax interest expense, net arising from equity offering and debt offering proceeds 4.1 Adjusted net income excluding special items and impact of interest expense, net arising from equity offering and debt offering proceeds $ 29.7 Diluted weighted-average shares used to compute earnings per common share 91.8 Weighted-average impact of 15.3 million shares issued in February 2020 equity offering (15.3) Diluted weighted-average shares excluding impact of shares issued in February 2020 equity offering 76.5 Adjusted EPS excluding special items and impact of equity offering and debt offering $ 0.39 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures, including adjustments related to contingent consideration; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non- recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results.

Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results.

lang=En&n=FD9B0E51-1 https://ec.ss.ec.gc.ca/auth/en/Services General Information Substance List CAS RN Substance Name Releases Releases (Speciated VOCs) Disposals Recycling Unit 103­23­1 Bis(2­ethylhexyl) adipate 0.0000 N/A N/A N/A tonnes 117­81­7 Bis(2­ethylhexyl) phthalate 0.0001 N/A N/A N/A tonnes 85­44­9 Phthalic anhydride N/A N/A N/A N/A tonnes Extension 73642 Fax: 4164994687 Email: darryl.chartrand@ch2m.com Contact Type Highest Ranking Employee Name: Robert Greenop Position: Plant Manager Telephone: 5199385865 Email: robert.greenop@polyone.com Mailing Address: Address Line 1:  City, Province/Territory, Postal Code: None  Country: None Contact Type Person who prepared the report Name: Najat Kamal Position: EHSQ specialist Telephone: 5148089920 Email: najat.kamal@polyone.com Mailing Address: Delivery Mode: GeneralDelivery Address Line 1:  City, Province/Territory, Postal Code: None  Country: None Number of employees: 16 Activities for Which the 20,000­Hour Employee Threshold Does Not Apply: None of the above Activities Relevant to Reporting Dioxins, Furans and Hexacholorobenzene: None of the above Activities Relevant to Reporting of Polycyclic Aromatic Hydrocarbons (PAHs): Wood preservation using creosote: No Is this the first time the facility is reporting to the NPRI (under current or past ownership): Is the facility controlled by another Canadian company or companies: Did the facility report under other environmental regulations or permits: Is the facility required to report one or more NPRI Part 4 substances (Criteria Air Contaminants): Operating Schedule ­ Days of the Week: Mon, Tue, Wed, Thu, Fri Usual Number of Operating Hours per day: 24 Usual Daily Start Time (24h) (hh:mm): 07:00 CAS RN Substance Name Releases Releases (Speciated VOCs) Disposals Recycling Unit Applicable Programs CAS RN Substance Name NPRI ON MOE TRA ON MOE Reg 127/01 First report for  this substance to  the ON MOE TRA 103­23­1 Bis(2­ethylhexyl) adipate Yes Yes Yes 117­81­7 Bis(2­ethylhexyl) phthalate Yes Yes No 85­44­9 Phthalic anhydride Yes Yes No General Information about the Substance ­ Releases and Transfers of the Substance Was the substance released on­site The substance will be reported as the sum of releases to all media (total of 1 tonne or less) 1 tonne or more of a Part 5 Substance (Speciated VOC) was released to air Yes Yes No Yes Yes No General Information about the Substance ­ Disposals and Off­site Transfers for Recycling Was the substance disposed of (on­site or off­ site), or transferred for treatment prior to final disposal Is the facility required to report on disposals of tailings and waste rock for the selected reporting Was the substance transferred off­site for recycling General Information about the Substance ­ Nature of Activities CAS RN Substance Name Manufacture the Substance Process the Substance Otherwise Use of the Substance 103­23­1 Bis(2­ethylhexyl) adipate For sale/distribution As a formulation component As a by­product 117­81­7 Bis(2­ethylhexyl) phthalate For sale/distribution As a formulation component As a by­product 85­44­9 Phthalic anhydride As a by­product As a reactant As a by­product TRA Quantifications CAS RN Substance Name Use, Creation, Contained in Product Quantity Use ranges for public reporting 103­23­1 Bis(2­ethylhexyl) adipate Use 0.000 tonnes Yes 103­23­1 Bis(2­ethylhexyl) adipate Creation 27.159 tonnes Yes 103­23­1 Bis(2­ethylhexyl) adipate Contained in Product 27.159 tonnes Yes 117­81­7 Bis(2­ethylhexyl) phthalate Use 0.000 tonnes Yes 117­81­7 Bis(2­ethylhexyl) phthalate Creation 0.104 tonnes Yes 117­81­7 Bis(2­ethylhexyl) phthalate Contained in Product 0.104 tonnes Yes 85­44­9 Phthalic anhydride Use 4228.7 tonnes Yes 85­44­9 Phthalic anhydride Creation 0.000 tonnes Yes 85­44­9 Phthalic anhydride Contained in Product 4228.7 tonnes Yes TRA Quantifications ­ Others Change in Method of Quantification Reasons for Description of how the change impact tracking and quantification of the substance Description of how an incident(s) affected quantifications Significant Process Change in Method of Quantification Reasons for Description of how the change impact tracking and quantification of the substance Description of how an incident(s) affected quantifications Significant Process Total Quantity Released (All Media) CAS RN Substance Name Category Basis of Estimate Detail Code Quantity 103­23­1 Bis(2­ethylhexyl) adipate Total Quantity Released O ­ Engineering Estimates 0.0000 tonnes 117­81­7 Bis(2­ethylhexyl) phthalate Total Quantity Released O ­ Engineering Estimates 0.0001 tonnes On­site Releases ­ Quarterly Breakdown of Annual Releases CAS RN Substance Name Quarter 1 Quarter 2 Quarter 3 Quarter 4 117­81­7 Bis(2­ethylhexyl) phthalate 25 25 25 25 On­site Releases ­ Reasons for Changes in Quantities Released from Previous Year CAS RN Substance Name Reasons for Changes in Quantities from Previous Year Comments 117­81­7 Bis(2­ethylhexyl) phthalate No significant change (i.e. 

With the assistance of management and any outside advisers the Committee deems appropriate (a) review and discuss with management the Company’s disclosures in the CD&A, and, based on this review, make a recommendation as to whether to include it in the Company’s annual report on Form 10-K and proxy statement relating to the Company’s 4 annual meeting of shareholders, and (b) prepare a Compensation Committee Report for inclusion in the Company’s proxy statement or other applicable SEC filings.

With the assistance of management and any outside advisers the Committee deems appropriate (a) review and discuss with management the Company’s disclosures in the CD&A, and, based on this review, make a recommendation as to whether to include it in the Company’s annual report on Form 10-K and proxy statement relating to the Company’s annual meeting of shareholders, and (b) prepare a Compensation Committee Report for inclusion in the Company’s proxy statement or other applicable SEC filings. 4 Board Reports and Annual Evaluation

Buyer must give Seller written notice of the existence of each claim involv- ing Product (whether based in contract, breach of warranty, negligence, strict liability, other tort or otherwise) immediately and in any case no later than the earlier of thirty (30) days after receipt of the quantity of Product forming the basis for the claim or applicable shelf-life expiration, if any. Ingen ændring eller tilføjelse til kontrakten skal ske ved Sælgers anerkendelse eller accept af en indkøbsordre, bekræftelse, frigivelse eller anden form indsendt af Køber, som indeholder yderligere eller anderledes vilkår eller betingelser. No modification or addition to the contract shall occur by the acknowledgment or acceptance by Seller of a purchase order, acknowledgment, release or other form submitted by Buyer containing additional or different terms or conditions 20.